New Key Statistics Module, Z-Score and F-Score
GREY:GLXKY Key Ratios
| Market Cap $ M | -- |
| Enterprise Value $ M | 3,171.50 |
| P/E(ttm) | 72.89 |
| PE Ratio without NRI | 62.14 |
| Forward PE Ratio | -- |
| Price/Book | 24.19 |
| Price/Sales | 12.49 |
| Price/Free Cash Flow | 78.08 |
| Price/Owner Earnings | 64.45 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -- |
| Beneish M-Score | -2.54 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 11.80 |
| y-y EBITDA Growth Rate % | -1.80 |
| EV-to-EBIT | 50.33 |
| EV-to-EBITDA | 46.38 |
| PEG | 5.27 |
| Shares Outstanding M | 677.62 |
| Net Margin (%) | 17.14 |
| Operating Margin % | 24.36 |
| Pre-tax Margin (%) | 23.71 |
| Quick Ratio | 1.49 |
| Current Ratio | 1.84 |
| ROA % (ttm) | 17.43 |
| ROE % (ttm) | 34.99 |
| ROIC % (ttm) | 47.94 |
| Dividend Yield % | -- |
| Altman Z-Score | 17.00 |
GLXKY Number of Guru Trades
GLXKY Volume of Guru Trades
Gurus Latest Trades with GREY:GLXKY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
GREY:GLXKY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
GlaxoSmithKline Pharmaceuticals Ltd Insider Transactions
No Available Data
News about GREY:GLXKY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers